• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同时进行[镓]Ga-PSMA-11 PET/MRI的前列腺病变的动态对比增强MRI:前列腺内病变之间的比较及灌注参数的相关性

Dynamic Contrast-Enhanced MRI of Prostate Lesions of Simultaneous [Ga]Ga-PSMA-11 PET/MRI: Comparison between Intraprostatic Lesions and Correlation between Perfusion Parameters.

作者信息

Zhao Jing, Kader Avan, Mangarova Dilyana B, Brangsch Julia, Brenner Winfried, Hamm Bernd, Makowski Marcus R

机构信息

Institute of Radiology and Nuclear Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany.

Department of Biology, Chemistry and Pharmacy, Institute of Biology, Freie Universität Berlin, Königin-Luise-Str. 1-3, 14195 Berlin, Germany.

出版信息

Cancers (Basel). 2021 Mar 19;13(6):1404. doi: 10.3390/cancers13061404.

DOI:10.3390/cancers13061404
PMID:33808685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8003484/
Abstract

We aimed to retrospectively compare the perfusion parameters measured from dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) of prostate benign lesions and malignant lesions to determine the relationship between perfusion parameters. DCE-MRI was performed in patients with PCa who underwent simultaneous [Ga]Ga-prostate-specific membrane antigen (PSMA)-11 positron emission tomography (PET)/MRI. Six perfusion parameters (arrival time (AT), time to peak (TTP), wash-in slope (W-in), wash-out slope (W-out), peak enhancement intensity (PEI), and initial area under the 60-s curve (iAUC)), and a semi-quantitative parameter, standardized uptake values maximum (SUVmax) were calculated by placing regions of interest in the largest area of the lesions. The DCE-MRI parameters between prostate benign and malignant lesions were compared. The DCE-MRI parameters in both the benign and malignant lesions subgroup with SUVmax ≤ 3.0 and SUVmax > 3.0 were compared. The correlation of DCE-MRI parameters was investigated. Malignant lesions demonstrated significantly shorter TTP and higher SUVmax than did benign lesions. In the benign and malignant lesions subgroup, perfusion parameters of lesions with SUVmax ≤ 3.0 show no significant difference to those with SUVmax > 3.0. DCE-MRI perfusion parameters show a close correlation with each other. DCE-MRI parameters reflect the perfusion characteristics of intraprostatic lesions with malignant lesions, demonstrating significantly shorter TTP. There is a moderate to strong correlation between DCE-MRI parameters. Semi-quantitative analysis reflects that malignant lesions show a significantly higher SUVmax than benign lesions.

摘要

我们旨在回顾性比较前列腺良性病变和恶性病变的动态对比增强(DCE)磁共振成像(MRI)测量的灌注参数,以确定灌注参数之间的关系。对同时接受[镓]镓-前列腺特异性膜抗原(PSMA)-11正电子发射断层扫描(PET)/MRI的前列腺癌患者进行DCE-MRI检查。通过在病变最大区域放置感兴趣区,计算六个灌注参数(达峰时间(AT)、峰值时间(TTP)、流入斜率(W-in)、流出斜率(W-out)、峰值增强强度(PEI)和60秒曲线下初始面积(iAUC))以及一个半定量参数——最大标准化摄取值(SUVmax)。比较前列腺良性和恶性病变之间的DCE-MRI参数。比较SUVmax≤3.0和SUVmax>3.0的良性和恶性病变亚组中的DCE-MRI参数。研究DCE-MRI参数的相关性。恶性病变的TTP明显短于良性病变,SUVmax高于良性病变。在良性和恶性病变亚组中,SUVmax≤3.0的病变灌注参数与SUVmax>3.0的病变灌注参数无显著差异。DCE-MRI灌注参数之间密切相关。DCE-MRI参数反映前列腺内恶性病变的灌注特征,其TTP明显较短。DCE-MRI参数之间存在中度至高度相关性。半定量分析表明,恶性病变的SUVmax明显高于良性病变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ba/8003484/63746fb712e0/cancers-13-01404-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ba/8003484/e74d05203855/cancers-13-01404-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ba/8003484/39bdee76c45d/cancers-13-01404-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ba/8003484/fa7b66d43e58/cancers-13-01404-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ba/8003484/63746fb712e0/cancers-13-01404-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ba/8003484/e74d05203855/cancers-13-01404-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ba/8003484/39bdee76c45d/cancers-13-01404-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ba/8003484/fa7b66d43e58/cancers-13-01404-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ba/8003484/63746fb712e0/cancers-13-01404-g004.jpg

相似文献

1
Dynamic Contrast-Enhanced MRI of Prostate Lesions of Simultaneous [Ga]Ga-PSMA-11 PET/MRI: Comparison between Intraprostatic Lesions and Correlation between Perfusion Parameters.同时进行[镓]Ga-PSMA-11 PET/MRI的前列腺病变的动态对比增强MRI:前列腺内病变之间的比较及灌注参数的相关性
Cancers (Basel). 2021 Mar 19;13(6):1404. doi: 10.3390/cancers13061404.
2
Can the Gleason score be predicted in patients with prostate cancer? A dynamic contrast-enhanced MRI, Ga-PSMA PET/CT, PSA, and PSA-density comparison study.前列腺癌患者的格里森评分可以预测吗?一项动态对比增强 MRI、Ga-PSMA PET/CT、PSA 和 PSA 密度比较研究。
Diagn Interv Radiol. 2023 Sep 5;29(5):647-655. doi: 10.4274/dir.2023.232186. Epub 2023 Jul 3.
3
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
4
Correlation Between Tumor Metabolism and Semiquantitative Perfusion Magnetic Resonance Imaging Metrics in Non-Small Cell Lung Cancer.非小细胞肺癌肿瘤代谢与磁共振灌注半定量成像指标的相关性
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):718-726. doi: 10.1016/j.ijrobp.2018.02.031. Epub 2018 Mar 2.
5
Diagnostic value of integrated F-PSMA-1007 PET/MRI compared with that of biparametric MRI for the detection of prostate cancer.集成F-PSMA-1007 PET/MRI与双参数MRI在检测前列腺癌方面的诊断价值比较
Prostate Int. 2022 Jun;10(2):108-116. doi: 10.1016/j.prnil.2022.03.003. Epub 2022 Mar 28.
6
SUVmax/ADC Ratio as a Molecular Imaging Biomarker for Diagnosis of Biopsy-Naïve Primary Prostate Cancer.SUVmax/ADC比值作为未经活检的原发性前列腺癌诊断的分子影像生物标志物
Indian J Nucl Med. 2021 Oct-Dec;36(4):377-384. doi: 10.4103/ijnm.ijnm_62_21. Epub 2021 Dec 15.
7
Factors Predicting Metastatic Disease in Ga-PSMA-11 PET-Positive Osseous Lesions in Prostate Cancer.预测前列腺癌 Ga-PSMA-11 PET 阳性骨病变转移疾病的因素。
J Nucl Med. 2020 Dec;61(12):1779-1785. doi: 10.2967/jnumed.119.241174. Epub 2020 Apr 17.
8
Diagnosis of spinal lesions using perfusion parameters measured by DCE-MRI and metabolism parameters measured by PET/CT.使用动态对比增强磁共振成像(DCE-MRI)测量的灌注参数和正电子发射断层显像/X射线计算机体层摄影(PET/CT)测量的代谢参数诊断脊柱病变。
Eur Spine J. 2020 May;29(5):1061-1070. doi: 10.1007/s00586-019-06213-9. Epub 2019 Nov 21.
9
Dynamic contrast-enhanced MRI versus F-FDG PET/CT: Which is better in differentiation between malignant and benign solitary pulmonary nodules?动态对比增强磁共振成像与氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描:在鉴别肺内孤立性良恶性结节方面哪种方法更优?
Chin J Cancer Res. 2018 Feb;30(1):21-30. doi: 10.21147/j.issn.1000-9604.2018.01.03.
10
Correlation between Intraprostatic PSMA Uptake and MRI PI-RADS of [Ga]Ga-PSMA-11 PET/MRI in Patients with Prostate Cancer: Comparison of PI-RADS Version 2.0 and PI-RADS Version 2.1.前列腺癌患者中[镓]镓-PSMA-11 PET/MRI的前列腺内PSMA摄取与MRI PI-RADS的相关性:PI-RADS第2.0版与PI-RADS第2.1版的比较
Cancers (Basel). 2020 Nov 26;12(12):3523. doi: 10.3390/cancers12123523.

引用本文的文献

1
Can the Gleason score be predicted in patients with prostate cancer? A dynamic contrast-enhanced MRI, Ga-PSMA PET/CT, PSA, and PSA-density comparison study.前列腺癌患者的格里森评分可以预测吗?一项动态对比增强 MRI、Ga-PSMA PET/CT、PSA 和 PSA 密度比较研究。
Diagn Interv Radiol. 2023 Sep 5;29(5):647-655. doi: 10.4274/dir.2023.232186. Epub 2023 Jul 3.
2
Detecting localised prostate cancer using radiomic features in PSMA PET and multiparametric MRI for biologically targeted radiation therapy.利用PSMA PET和多参数MRI中的放射组学特征检测局限性前列腺癌以进行生物靶向放射治疗。
EJNMMI Res. 2023 Apr 26;13(1):34. doi: 10.1186/s13550-023-00984-5.
3

本文引用的文献

1
Molecular MR Imaging of Prostate Cancer.前列腺癌的分子磁共振成像
Biomedicines. 2020 Dec 22;9(1):1. doi: 10.3390/biomedicines9010001.
2
Lesion-to-background ratio threshold value of SUVmax of simultaneous [Ga]Ga-PSMA-11 PET/MRI imaging in patients with prostate cancer.前列腺癌患者同时进行[镓]镓-PSMA-11 PET/MRI成像时SUVmax的病变与背景比值阈值
Insights Imaging. 2020 Dec 17;11(1):137. doi: 10.1186/s13244-020-00926-y.
3
Correlation between Intraprostatic PSMA Uptake and MRI PI-RADS of [Ga]Ga-PSMA-11 PET/MRI in Patients with Prostate Cancer: Comparison of PI-RADS Version 2.0 and PI-RADS Version 2.1.
Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET.
用于基于PSMA PET的前列腺癌PSMA-RADS分类的深度学习与影像组学框架
EJNMMI Res. 2022 Dec 29;12(1):76. doi: 10.1186/s13550-022-00948-1.
4
Semi-quantitative and quantitative dynamic contrast-enhanced (DCE) MRI parameters as prostate cancer imaging biomarkers for biologically targeted radiation therapy.半定量和定量动态对比增强(DCE)MRI 参数作为生物靶向放射治疗的前列腺癌成像生物标志物。
Cancer Imaging. 2022 Dec 19;22(1):71. doi: 10.1186/s40644-022-00508-9.
5
Visualization and Quantification of the Extracellular Matrix in Prostate Cancer Using an Elastin Specific Molecular Probe.使用弹性蛋白特异性分子探针可视化和定量前列腺癌中的细胞外基质
Biology (Basel). 2021 Nov 22;10(11):1217. doi: 10.3390/biology10111217.
前列腺癌患者中[镓]镓-PSMA-11 PET/MRI的前列腺内PSMA摄取与MRI PI-RADS的相关性:PI-RADS第2.0版与PI-RADS第2.1版的比较
Cancers (Basel). 2020 Nov 26;12(12):3523. doi: 10.3390/cancers12123523.
4
Whole-Body Integrated [Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer: Comparison with Whole-Body PET/CT as the Standard of Reference.全身整合 [Ga]PSMA-11-PET/MR 成像在复发性前列腺癌患者中的应用:与全身 PET/CT 作为参考标准的比较。
Mol Imaging Biol. 2020 Jun;22(3):788-796. doi: 10.1007/s11307-019-01424-4.
5
The Use of MRI and PET Imaging Studies for Prostate Cancer Management: Brief Update, Clinical Recommendations, and Technological Limitations.磁共振成像(MRI)和正电子发射断层扫描(PET)成像研究在前列腺癌管理中的应用:简要更新、临床建议及技术局限性
Med Sci (Basel). 2019 Aug 5;7(8):85. doi: 10.3390/medsci7080085.
6
Detection Rate and Localization of Prostate Cancer Recurrence Using Ga-PSMA-11 PET/MRI in Patients with Low PSA Values ≤ 0.5 ng/mL.使用 Ga-PSMA-11 PET/MRI 检测低 PSA 值(≤0.5ng/mL)前列腺癌患者的复发情况及其定位。
J Nucl Med. 2020 Feb;61(2):194-201. doi: 10.2967/jnumed.118.225276. Epub 2019 Aug 2.
7
Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2.前列腺影像报告和数据系统第 2.1 版:前列腺影像报告和数据系统第 2 版 2019 年更新。
Eur Urol. 2019 Sep;76(3):340-351. doi: 10.1016/j.eururo.2019.02.033. Epub 2019 Mar 18.
8
Compressed Sensing Radial Sampling MRI of Prostate Perfusion: Utility for Detection of Prostate Cancer.前列腺灌注磁共振压缩感知径向采样:用于前列腺癌检测的效用。
Radiology. 2019 Mar;290(3):702-708. doi: 10.1148/radiol.2018180556. Epub 2019 Jan 1.
9
Immunohistochemical Validation of PSMA Expression Measured by Ga-PSMA PET/CT in Primary Prostate Cancer.Ga-PSMA PET/CT 测量原发性前列腺癌中 PSMA 表达的免疫组化验证。
J Nucl Med. 2018 Feb;59(2):238-243. doi: 10.2967/jnumed.117.195172. Epub 2017 Aug 3.
10
Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0.镓-前列腺特异性膜抗原正电子发射断层显像/计算机断层扫描:欧洲核医学协会和美国核医学与分子影像学会联合发布的前列腺癌成像程序指南:第1.0版
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1014-1024. doi: 10.1007/s00259-017-3670-z.